Does FOLFIRINOX have an immune modulatory effect on resectable pancreatic cancer?

B
Bert O'Neil, MD

Primary Investigator

J
Jessica MacLean

Primary Investigator

Overview

The purpose of this study is to determine if combination chemotherapy with FOLFIRINOX modulates the immune response inf localized pancreatic cancer.

Description

The purpose of this study is to determine if combination chemotherapy with FOLFIRINOX modulates the immune response inf localized pancreatic cancer.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    pancreatic cancer
  • Age: - 100 Years
  • Gender: All
Updated on 20 Nov 2022. Study ID: 1705457995

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center